(This NTF. Supersited vide NTF. NO. 14/2008-CE(N.T.), DT. 01/03/2008)

NTF. NO. 02/2005-CE(N.T.), DT. 07/01/2005

P & P and other medicines subjected to excise on MRP basis with effect from January 8; Abatement of 35 % allowed
In exercise of the powers conferred by sub-section (1) and sub-section (2) of section 4A of the Central Excise Act, 1944 (1 of 1944), the Central Government hereby specifies the goods mentioned in column (3) of the Table below and falling under Chapter or Heading No. [OLD Chapter ] [OLD Chapter or Heading No. or Sub-heading No.] of the First Schedule to the Central Excise Tariff Act, 1985 (5 of 1986) mentioned in the corresponding entry in column (2) of the said Table, as the goods to which the provisions of the said sub-section (2) shall apply, and allows as abatement the percentage of retail sale price mentioned in the corresponding entry in column (4) of the said

S. No.	Chapter or Heading No. [OLD Chapter ] [OLDChapter or Heading No. or Sub-heading No.]	Description	Abatement as a percentage of retail sale price
(1)	(2)	(3)	(4)
1.	3003 or 3004 [OLD- 30 ] [OLD- 3003.10 ]	Patent or proprietary medicaments, other than those medicaments which are exclusively Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic	42.5% [OLD- 40% ][OLD- 35% ]
2.	3003 or 3004 [OLD-30] [OLD-3003.20 ]	Medicaments (other than patent or proprietary) other than those which are exclusively used in Ayurvedic, Unani, Siddha, Homoeopathic or Bio-chemic systems	42.5% [OLD-40% ] [OLD-35%]

(In above table entry in column (4), at Sl.no. 1 & 2 (42.5%) has been substituted vide NTF. NO. 02/2007-CE(N.T.), DT. 31/01/2007 & come into force on the 01/02/2007)

(In above table entry in column (4), at Sl.No. 1 & 2 has been substituted vide NTF. No. 04/2005-CE(N.T.), DT. 23/02/2005)

2. This notification shall come into force on the 8th day of January, 2005.

Explanation 1.-For the purposes of this notification,”retail sale price” means the retail price displayed by the manufacturer under the provisions of the Drugs (Prices Control) Order,1995.

Explanation 2.- For the purposes of this notification, "Patent or proprietary medicaments" means any drug or medicinal preparation, in whatever form, for use in the internal or external treatment of, or for the prevention of ailments in human beings or animals, which bears either on itself or on its container or both, a name which is not specified in a monograph, in a Pharmacopoeia, Formulary or other publications, namely:-

(a) the Indian Pharmacopoeia;

(b) the International Pharmacopoeia;

(c) the National Formulary of India;

(d) the British Pharmacopoeia;

(e) the British Pharmaceutical Codex;

(f) the British Veterinary Codex;

(g) the United States Pharmacopoeia;

(h) the National Formulary of the U.S.A.;

(i) the Dental Formulary of the U.S.A.; and

(j) the State Pharmacopoeia of the U.S.S.R.,

or which is a brand name, that is, a name or a registered trade mark under the Trade marks Act, 1999 (47 of 1999), or any other mark such as a symbol, monogram, label, signature or invented words or any writing which is used in relation to that medicine for the purpose of indicating or so as to indicate a connection in the course of trade between the medicine and some person, having the right either as proprietor or otherwise to use the name or mark with or without any indication of the identity of that person.

[OLD-
Explanation - For the purposes of this notification, “ retail sale price” means the retail price displayed by the manufacturer under the provisions of the Drugs (Prices Control) Order, 1995. ]

(In above Notification the words "Chapter or Heading No." & column 2 at Sl.No. 1 & 2 in table has been substituted vide NTF. NO. 29/2007-CE(NT), DT. 06/06/2007)

(In above Notification the words "Chapter" , in table column 2 at Sl.No. 1 & 2 and Explanation has been substituted vide NTF. NO. 28/2006-CE(NT), DT. 29/12/2006)

(F.No.354/100/2004-TRU)

V.Sivasubramanian
Deputy Secretary to the Government of India

Presented by eximkey.com